• Scientists used quantitative analysis to trial anti-cancer agent
    5-allyl-7-gen-difluoromethoxychrysin (AFMC) can increase the effect of current anti-cancer agents.

Electrophoretic Separations

Scientists used quantitative analysis to trial anti-cancer agent

Aug 01 2011

Using quantitative analysis methods, a team of scientists have discovered that a novel synthetic analogue of chrysin can be used to increase the effectiveness of anti-cancer agents.

In a study published by BMC Cancer, Chinese scientists investigated whether 5-allyl-7-gen-difluoromethoxychrysin (AFMC) could inhibit proliferation in various cancer cell lines and promote tumour necrosis.

In a method involving flow cytometry, propidium iodide fluorescence staining and agarose gel electrophoresis, the scientists found that subtoxic concentrations of AFMC make human non-small cell lung cancer (NSCLC) A549 cells more sensitive to tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apoptosis.

Additionally, the study found that treating A549 cells with AFMC considerably provoked the expression of death receptor 5 (DR5), while also increasing the proliferation of Sub-G1 cells.

However, AFMC-mediated induction of DR5 expression was not observed in human embryo lung WI-38 cells, and AFMC did not makeWI-38 cells more sensitive to TRAIL-induced apoptosis.

The team suggested that AFMC "synergistically enhances TRAIL-mediated apoptosis in NSCLC cells" by increasing the amounts of DR5.

Digital Edition

Chromatography Today - Buyers' Guide 2022

October 2023

In This Edition Modern & Practical Applications - Accelerating ADC Development with Mass Spectrometry - Implementing High-Resolution Ion Mobility into Peptide Mapping Workflows Chromatogr...

View all digital editions


MSB 2024

May 19 2024 Brno, Czech Republic

Water Expo Nigeria 2024

May 21 2024 Lagos, Nigeria

NGVS 2024

May 23 2024 Beijing, China


May 28 2024 Tel Aviv, Israel


May 28 2024 Leuven, Belgium

View all events